| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 9,389,000 | 8,024,000 | 7,145,000 | 8,226,000 | | Cost of Revenue | 3,985,000 | 3,945,000 | 3,907,000 | 3,857,000 | | | Gross Profit | 5,404,000 | 4,079,000 | 3,238,000 | 4,369,000 | | | Operating Expenses | | Research Development | 1,430,000 | 1,303,000 | 1,317,000 | 1,316,000 | | Selling General and Administrative | 1,316,000 | 2,697,000 | 1,200,000 | 1,263,000 | | Non Recurring | 63,000 | 91,000 | 74,000 | 251,000 | | Others | 16,000 |
-
|
-
|
-
| | | | Total Operating Expenses | 2,825,000 |
-
|
-
|
-
| | | | Operating Income or Loss | 2,579,000 | (12,000) | 647,000 | 1,539,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (150,000) | 95,000 | (1,170,000) | | Earnings Before Interest And Taxes | 2,531,000 | (49,000) | 629,000 | 369,000 | | Interest Expense | (1,000) | 1,000 |
-
|
-
| | Income Before Tax | 2,532,000 | (50,000) | 629,000 | 369,000 | | Income Tax Expense | 676,000 | 348,000 |
-
| 135,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 1,595,000 | (398,000) | 629,000 | 234,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 1,856,000 | (398,000) | 629,000 | 234,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $1,856,000 | ($398,000) | $629,000 | $234,000 |
|
2.03% Nasdaq 
Income Statement
